Tag: asthma research
Fasenra 30 Mg/Ml Subcutaneous Syringe Monoclonal Antibody, Human Interleukin 5 Antagonist
Discover the transformative impact of Fasenra (benralizumab), a groundbreaking monoclonal antibody targeting interleukin-5, specifically designed for individuals with severe eosinophilic asthma. This treatment not only helps to significantly lower eosinophil levels and mitigate asthma exacerbations but also enhances patients’ quality of life through tailored management strategies. Explore our comprehensive guide to understand its benefits, risks,…